PDT Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64,304
| Closed | -$143K | – | 678 |
|
|
2025
Q1 | $143K | Hold |
64,304
| – | – | 0.01% | 702 |
|
|
2024
Q4 | $188K | Hold |
64,304
| – | – | 0.02% | 664 |
|
|
2024
Q3 | $167K | Sell |
64,304
-173,884
| -73% | -$452K | 0.01% | 672 |
|
|
2024
Q2 | $705K | Sell |
238,188
-9,290
| -4% | -$27.5K | 0.07% | 408 |
|
|
2024
Q1 | $1.12M | Buy |
247,478
+100
| +0% | +$453 | 0.11% | 310 |
|
|
2023
Q4 | $1.41M | Buy |
247,378
+37,302
| +18% | +$213K | 0.16% | 226 |
|
|
2023
Q3 | $966K | Buy |
210,076
+125,612
| +149% | +$578K | 0.12% | 291 |
|
|
2023
Q2 | $546K | Hold |
84,464
| – | – | 0.08% | 364 |
|
|
2023
Q1 | $637K | Buy |
+84,464
| New | +$637K | 0.09% | 347 |
|
|
2022
Q4 | – | Sell |
-96,417
| Closed | -$954K | – | 603 |
|
|
2022
Q3 | $954K | Sell |
96,417
-44,975
| -32% | -$445K | 0.14% | 233 |
|
|
2022
Q2 | $1.51M | Buy |
+141,392
| New | +$1.51M | 0.13% | 246 |
|